APVO - Aptevo Therapeutics GAAP EPS of $1.57 beats by $0.64 revenue of $3.11M in-line
2023-03-30 09:10:45 ET
- Aptevo Therapeutics press release ( NASDAQ: APVO ): FY GAAP EPS of $1.57 beats by $0.64 .
- Revenue of $3.11M (-74.7% Y/Y) in-line.
- Aptevo had cash and cash equivalents as of December 31, 2022 totaling $22.6 million.
For further details see:
Aptevo Therapeutics GAAP EPS of $1.57 beats by $0.64, revenue of $3.11M in-line